The Dermatology Digest

FEBRUARY 8, 2024

The Dermatology Digest asked key thought leaders and editorial advisory board members to take out their crystal balls and weigh in on what’s to come in 2024 and beyond. Inside the Burgeoning AD Pipeline AD is another dermatologic condition that is undergoing a transformation in terms of treatment options and paradigms.

Dermatology 78

Dermatology Eczema Pharmaceutical Dermatitis 78

The Dermatology Digest

MARCH 7, 2024

Elizabeth (Lisa) Swanson, MD, a pediatric dermatologist in Boise, ID, discusses advances in treating kids with atopic dermatitis, psoriasis, vitiligo, alopecia areata, and hemangiomas. Watch Now [the_ad id="7336"] [the_ad id="8980"] The post Welcome to the Golden Age of Pediatric Dermatology appeared first on The Dermatology Digest.

Dermatology 68

Dermatology Dermatitis Therapy 68

Dermatology Times

JUNE 10, 2024

David Rosmarin, MD, shares key points from phase 3 data of ruxolitinib for vitiligo, as well as highlights the potential for targeting the STAT pathway in upcoming atopic dermatitis therapeutics.

Dermatitis 85

Dermatitis 85

Dermatology Times

DECEMBER 27, 2024

As 2024 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in atopic dermatitis this year.

Dermatitis 41

Dermatitis Dermatology Therapy 41

Dermatology Times

JUNE 1, 2024

Raj Chovatiya, MD, PhD, takes a deep dive in the challenges, solutions, and further research needed to treat seborrheic dermatitis.

Dermatitis 80

Dermatitis Treatments 80

Dermatology Times

MAY 15, 2024

In this month’s Cosmetic Conundrums column, explore what dermatology clinicians need to know about false eyelashes to help prevent infections or contact dermatitis.

Dermatology 74

Dermatology Dermatitis 74

Dermatology Times

OCTOBER 1, 2023

October is Eczema Awareness Month and Dermatology Times is recognizing research to best serve patients with the most common type of eczema, atopic dermatitis.

Dermatitis 74

Dermatitis Eczema Dermatology 74

Dermatology Times

DECEMBER 5, 2023

Zakiya Pressley Rice, MD, took a deep dive into how atopic dermatitis severity and increased rates of grade school absenteeism affect patients with skin of color during a recent Masterclasses in Dermatology meeting.

Dermatitis 78

Dermatitis Dermatology 78

Dermatology Times

MAY 7, 2024

A 5-expert panel delves into atopic dermatitis guidelines and recommendations and recent studies to make note of.

Dermatitis 88

Dermatitis Clinic Treatments 88

Dermatology Times

JUNE 10, 2024

Melinda Gooderham, MSc, MD, FRCPC, discusses potential new biologics for atopic dermatitis that target IL-22, IL-33, OX40, and more.

Dermatitis 74

Dermatitis 74

Dermatology Times

APRIL 12, 2024

Dr Alexandra Golant discusses managing multiple conditions in a 17-year-old African American waitress, highlighting the complexities of treating moderate-to-severe atopic dermatitis alongside severe acne and oral contraceptives. She also addresses potential drug interactions, focusing on the safety of dupilumab in systemic treatment.

Dermatitis 85

Dermatitis Treatments Safety Management 85

Dermatology Times

DECEMBER 6, 2024

A study using proteome-wide association techniques identified novel protein biomarkers for atopic dermatitis.

Dermatitis 81

Dermatitis 81

Dermatology Times

JUNE 11, 2024

Gil Yosipovitch, MD, addresses the severity of chronic itch and sleep disturbances in patients with atopic dermatitis.

Dermatitis 77

Dermatitis 77

Dermatology Times

JANUARY 22, 2024

Zoryve was approved for the treatment of seborrheic dermatitis in patients ages 9 years and older in December.

Dermatitis 78

Dermatitis Treatments 78

Dermatology Times

MAY 30, 2024

Raj Chovatiya, MD, PhD, reviews the varying degrees of influence of skin barrier disruption, immune dysregulation, and Malassezia yeast in seborrheic dermatitis.

Dermatitis 74

Dermatitis 74

Dermatology Times

NOVEMBER 12, 2023

What are some of the challenges and triumphs in using biologics for atopic dermatitis? Allen, RN, NP, shares insights at the American College of Allergy, Asthma and Immunology 2023 Annual Scientific Meeting.

Dermatitis 87

Dermatitis 87

Dermatology Times

APRIL 18, 2024

Researchers noted that further examination and monitoring for headache disorders in patients with atopic dermatitis may be warranted.

Dermatitis 78

Dermatitis 78

Dermatology Times

JULY 13, 2024

Lio discusses his SPD 2024 non-CME talk, new and exciting innovations in pediatric atopic dermatitis, and more.

Dermatitis 78

Dermatitis Innovations 78

Dermatology Times

NOVEMBER 4, 2023

Test your knowledge on approved biologics in the management of moderate to severe atopic dermatitis and considerations for an 18-year-old man's case.

Dermatitis 78

Dermatitis Management 78

Dermatology Times

DECEMBER 11, 2023

A poster from the 2023 Revolutionizing Atopic Dermatitis Conference revealed a link between AD, impaired oral health, and oral dysbiosis.

Dermatitis 81

Dermatitis 81

Dermatology Times

JANUARY 23, 2024

A study explored the prioritization habits of both patients with atopic dermatitis and their caregivers when it comes to treatment.

Dermatitis 78

Dermatitis Management Treatments 78

Dermatology Times

JUNE 11, 2024

Kristine Kucera, PA-C, MPAS, DHS, discusses the atopic dermatitis patient experience alongside one of her patients, Mickey Bryson.

Dermatitis 74

Dermatitis 74

Dermatology Times

SEPTEMBER 6, 2023

As we approach National Eczema Week and National Eczema Month, take a look at the most influential atopic dermatitis research from the last decade.

Dermatitis 78

Dermatitis Eczema 78

The Dermatology Digest

OCTOBER 29, 2024

Linda Stein Gold, MD, Director of Dermatology Clinical Research at Henry Ford Health System in Detroit, MI, reviews new data on atopic dermatitis (AD) patients who switched to lebrikizumab (Ebyglyss, Lilly) from dupilumab (Dupixent, Sanofi and Regeneron) that was presented at the 2024 Fall Clinical Dermatology Conference in Las Vegas, NV. “If

Dermatitis 78

Dermatitis Clinic Dermatology Treatments 78

Dermatology Times

OCTOBER 3, 2024

Jason Hawkes, MD, MS, emphasized the importance of biologic treatments transforming the management of both prurigo nodularis and atopic dermatitis.

Dermatitis 74

Dermatitis Clinic Management Treatments 74

Dermatology Times

NOVEMBER 10, 2023

A new study presented at this year’s American College of Allergy, Asthma and Immunology Annual Scientific Meeting highlights the need for mental health support in patients with atopic dermatitis.

Dermatitis 78

Dermatitis 78

Dermatology Times

JANUARY 9, 2024

Test your knowledge and explore a recent study on the relationship between alcohol consumption and skin diseases, including atopic dermatitis.

Dermatitis 74

Dermatitis 74

The Dermatology Digest

JANUARY 2, 2025

The post ILDS Raises Awareness of Skin Conditions Around the World appeared first on The Dermatology Digest.

Dermatitis 74

Dermatitis Dermatology 74

Dermatology Times

JANUARY 11, 2024

Innovative practice pearls for both vitiligo and atopic dermatitis treatment were shared with nearly 200 clinicians to put into practice at the virtual Revolutionizing Vitiligo and Revolutionizing Atopic Dermatitis Conferences.

Dermatitis 74

Dermatitis Innovations Treatments 74

Dermatology Times

MARCH 9, 2024

Lio delves into his American Academy of Dermatology Annual Meeting session, "Dietary Triggers and Modifications of Common Dermatologic Conditions: An Evidence Based Approach."

Dermatitis 88

Dermatitis Dermatology 88

Dermatology Times

SEPTEMBER 30, 2023

Colleen Cotton, MD, does a deep dive on pediatric atopic dermatitis and explains the importance of timing and conversations with patients about different treatments.

Dermatitis 78

Dermatitis Treatments 78

Dermatology Times

FEBRUARY 23, 2024

Researchers have found Staphylococcus aureus may trigger itchiness in atopic dermatitis, opening the door to new treatment approaches in the future.

Dermatitis 69

Dermatitis Treatments 69

Dermatology Times

MAY 14, 2024

A 5-expert panel continues their conversation on atopic dermatitis, exploring beyond steroids and addressing unmet needs.

Dermatitis 74

Dermatitis Clinic Treatments 74

Dermatology Times

MAY 21, 2024

A 5-expert panel continues their conversation on atopic dermatitis, discussing patient-centered care and key takeaways.

Dermatitis 74

Dermatitis Clinic Treatments 74

Dermatology Times

DECEMBER 11, 2023

Jennifer Etienne shared her experiences during the shared decision-making patient panel of the 2023 Revolutionizing Atopic Dermatitis Virtual Conference.

Dermatitis 73

Dermatitis 73

Dermatology Times

OCTOBER 31, 2024

Egeberg discusses promising new treatments and insights from recent clinical trials, highlighting significant advancements in chronic hand eczema and atopic dermatitis care presented at the EADV 2024.

Eczema 74

Eczema Dermatitis Clinic Treatments 74

Dermatology Times

DECEMBER 15, 2023

is the first FDA-approved drug for seborrheic dermatitis with a new mechanism of action in over 2 decades. Roflumilast foam 0.3% Christopher Bunick, MD, PhD; Shawn Kwatra, MD; and Peter Lio, MD, share expert insights.

Dermatitis 74

Dermatitis 74